Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Brain Imaging Behav. 2021 Jun;15(3):1364–1373. doi: 10.1007/s11682-020-00335-1

Table 3.

Endogenous and net oxidative DNA damage as per Comet assay by case-control group and timepoint

Endogenous DNA damage Oxidative DNA damage

TM Mean (SD) TMFPG-net Mean (SD) TMEndoIII-net Mean (SD)
Baseline Follow-up Baseline Follow-up Baseline Follow-up

Controls (n=12) 1.26 (0.45) 1.05 (0.55) 7.88 (4.18) 7.12 (3.45) 0.92 (0.98) 0.84 (0.75)
Cases (n=13) 1.22 (1) 1.22 (1.01) 9.36 (2.68) 9 (5.83) 1.27 (1.29) 2.03 (2.13)
TI Mean (SD) TIFPG-net Mean (SD) TIEndoIII-net Mean (SD)

Baseline Follow-up Baseline Follow-up Baseline Follow-up

Controls (n=12) 9.14 (1.98) 8.04 (1.87) 21.81 (9.5) 20.58 (8.63) 4.37 (3.58) 4.22 (3.3)
Cases (n=13) 8.77 (3.44) 8.69 (3.86) 27.11 (7) 26.09 (10.87) 6.61 (5.08) 9.15 (6.73)*

TM and TI, Tail moment and Tail intensity, mean values expressed in arbitrary units; TMEndo-net and TIEndo-net, net oxidative DNA damage measured after EndoIII treatment; TMFPG-net and TIFPG-net, net oxidative DNA damage after FpG treatment.

*

p < 0.05 between group significance;

p < 0.05 within group significance.